. SDS-PAGE analysis of the purified MecI ······································ SI3 Table S1 . Analysis of bla/mec system of S. aureus ······································· SI13
References ······································································································ SI14
Experimental Procedures
Cloning of the mecI gene. Genomic DNA from S. aureus NRS70 (N315) was used as the template for cloning.
The PCR was performed using the following oligonucleotide primers: mecI_fw, 5'-GATATACATATGGATAATAAAACGTATG-3' (NdeI restriction site shown underlined) and mecI_rv3, 5'-CTCAAGCTTATTTTTTATTCAATATATTTCTCAATTCTTC -3' (HindIII restriction site shown underlined).
The conditions used for the PCR were as follows: 30 cycles of denaturation at 94 °C for 40 s followed by annealing of primers for 40 s at 60 °C; extension for 1 min at 72 °C using Pfu Ultra II DNA polymerase (Stratagene). The reaction volume was 50 µL and contained 10X buffer with 4 mM MgSO 4 , 0.2 mM triphosphoryldeoxynucleotides, 0.5 µM of each primer, 50 ng of template DNA, 5% DMSO and 1 µL of Pfu Ultra II DNA polymerase. The PCR reaction mixture was subjected to electrophoresis in a 1.5% agarose gel for 25 min at 100 V, and the product was excised and purified using a gel extraction kit (Qiagen). Double digest reaction mixtures using both restriction endonucleases NdeI and HindIII were carried out on both the PCR product and the empty pET24a(+) vector, and the purified DNA fragments were ligated using T4 DNA ligase (Invitrogen). The ligation mixture was used to transform Escherichia coli DH5α (Invitrogen) competent cells.
Transformants were selected on LB-agar plates supplemented with 50 µg/mL of kanamycin. To confirm the presence of the inserted mecI gene, first we did a colony PCR from several transformants followed by plasmid preparation and digestion with NdeI and HindIII restriction enzymes. Subsequently, the entire nucleotide sequence of the mecI gene was verified by sequencing. The plasmid was designated as pET24-mecI.
MecI expression in E. coli and purification. We used a modified literature method for this purification. AAATACTACATTTGTAATATACTACAAATGTAGTCTTATAT were annealed at a 1:1 ratio. Annealing was carried out by heating the reaction mixture to 95 °C for 5 min, followed by slow cooling (overnight) to room temperature in 10 mM Tris pH 7.5. The annealed sample was run on an 18% acrylamide gel in 0.5x Tris-borate-EDTA buffer (TBE), the dsDNA was purified from the gel following the procedure described by Green & Sambrook, 2 and the concentration was determined from the absorbance at 260 nm. The bla dsDNA (bla operator), previously designated R1-Z dsDNA, was prepared as described. 1 We combined MecI or BlaI at different concentrations with 0.15 µM mec dsDNA or bla dsDNA in 20 mM MOPS, 200 mM NaCl, 20 mM 
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MgCl 2 , and 5% glycerol, pH 7.4 and after 45 min of incubation at 22 °C, the resulting mixtures were loaded on an 18% non-denaturing polyacrylamide gel. The gel was subjected to electrophoresis in 0.5X TBE with refrigeration at 70 V for 5 hours ( Figure S4 ). Two protein-DNA complexes could be resolved in the polyacrylamide gel. The same EMSA procedure was followed for BlaI protein with 0.15 µM mec dsDNA or bla dsDNA (figure S5)
MALDI mass spectroscopy analysis of MecI-dsDNA complexes: We first attempted to characterize the complexes formed at the protein and DNA concentrations used in the EMSA, but the amounts of the different species were too low for detection by MALDI mass spectroscopy. MecI (12 µM ) was incubated with 1 µM mec dsDNA for 45 minutes at 22°C, and the mixture was subjected to MALDI mass spectrometry. Under this condition, it was possible to detect two species, which based on their masses (39,188 Da and 54,685 Da) were assigned to the monomer-DNA and dimer-DNA complexes. We also verified by MALDI mass spectrometry, that MecI forms oligomers at 12 µM; we could detect the monomeric, dimeric, trimeric, tetrameric and pentameric species (Figure 2A) . 
Sedimentation equilibrium assay (SE). Short columns (85 μL) SE experiments of MecI samples (0.5-36 µM)
were carried out at speeds ranging from 16,500 to 24,000 rpm and at several wavelengths (229-296 nm), using the same experimental conditions and instrument as in the SV experiments. After the last equilibrium scan, a high-speed centrifugation run (48,000 rpm) was done to estimate the corresponding baseline offsets. Weightaverage buoyant molecular weights of protein were determined by fitting a single species model to the experimental data using the HeteroAnalysis program 6 and corrected for solvent composition and temperature with the program SEDNTERP. 5 Data collected at different speeds and different loading concentrations were further analyzed globally in terms of different self-association models using SEDPHAT 9.4 software 7 ( Figure   S7 ). Data analysis revealed that MecI exists in solution as a mixture of monomers and dimers at equilibrium with a dissociation constant of 0.30 ± 0.03 µM. The observed changes in the average molecular weight evidenced that at high concentration (36 µM) MecI appears mainly as a dimer, Figure S8 shows SE data obtained for MecI at 36 µM and the best-fit analysis assuming the monomer and two different association models. These results were consistent with the SV studies reported above. The program DynaFit 8 was then used to calculate the concentration of monomer and dimer, and this simulation showed that MecI was present in 
Determination of the in vivo concentration of MecI. The concentrations of MecI in S. aureus NRS70 (N315)
and MRSA252 strains were determined from cultures grown in the absence of β-lactam antibiotics to exponential and stationary phase, following the procedure previously described. 1 In the case of S. aureus MRSA252, as a control to corroborate the identity of the MecI band, oxacillin was added to the cells in the exponential phase (OD 625 of 0.8) at sub-MIC concentration (0.05 µg/mL), and the culture was then harvested in stationary phase (OD 625 of 2.3). The MecI bands were quantified using the Image Lab software (BioRad) ( Figure   S10 ). Western blotting with purified MecI and BlaI indicated that there was not any cross-reactivity with the anti-MecI antibody ( Figure S11 ).
Characterization of MecI and BlaI binding to bla and mec operator sequences by fluorescence anisotropy.
The dissociation constants for MecI or BlaI binding to the bla and mec operator regions were determined by the Table S1 . Analysis of the bla/mec systems of S. aureus genomes deposited at NCBI database 11, 12 (revised by December 2013).
